ES357071A1 - Un procedimiento para la obtencion de un preparado farma- ceutico apto para administracion oral. - Google Patents

Un procedimiento para la obtencion de un preparado farma- ceutico apto para administracion oral.

Info

Publication number
ES357071A1
ES357071A1 ES357071A ES357071A ES357071A1 ES 357071 A1 ES357071 A1 ES 357071A1 ES 357071 A ES357071 A ES 357071A ES 357071 A ES357071 A ES 357071A ES 357071 A1 ES357071 A1 ES 357071A1
Authority
ES
Spain
Prior art keywords
base
resin
imipramine
polymer containing
carrier liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES357071A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
JR Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JR Geigy AG filed Critical JR Geigy AG
Publication of ES357071A1 publication Critical patent/ES357071A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Loading And Unloading Of Fuel Tanks Or Ships (AREA)
ES357071A 1967-08-12 1968-08-09 Un procedimiento para la obtencion de un preparado farma- ceutico apto para administracion oral. Expired ES357071A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB37136/67A GB1176194A (en) 1967-08-12 1967-08-12 Pharmaceutical Compositions

Publications (1)

Publication Number Publication Date
ES357071A1 true ES357071A1 (es) 1970-02-16

Family

ID=10394029

Family Applications (1)

Application Number Title Priority Date Filing Date
ES357071A Expired ES357071A1 (es) 1967-08-12 1968-08-09 Un procedimiento para la obtencion de un preparado farma- ceutico apto para administracion oral.

Country Status (19)

Country Link
US (1) US3665073A (esLanguage)
JP (1) JPS4823889B1 (esLanguage)
AT (1) AT288592B (esLanguage)
BE (1) BE719263A (esLanguage)
CA (1) CA920949A (esLanguage)
CS (1) CS159232B2 (esLanguage)
CY (1) CY681A (esLanguage)
DE (1) DE1792233B1 (esLanguage)
DK (1) DK123141B (esLanguage)
ES (1) ES357071A1 (esLanguage)
FI (1) FI48974C (esLanguage)
FR (1) FR7751M (esLanguage)
GB (1) GB1176194A (esLanguage)
IE (1) IE32264B1 (esLanguage)
IL (1) IL30529A (esLanguage)
MY (1) MY7300271A (esLanguage)
NL (1) NL6811233A (esLanguage)
NO (1) NO128308B (esLanguage)
SE (1) SE376548B (esLanguage)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3762266A (en) * 1970-11-09 1973-10-02 Gould Inc Bimetal fastener
US3947572A (en) * 1974-07-01 1976-03-30 Abbott Laboratories Iron-resin adsorbate
US4015599A (en) * 1975-07-21 1977-04-05 Rohm And Haas Company Anesthetic delivery system
JPS64734U (esLanguage) * 1987-06-20 1989-01-05
SE9103110D0 (sv) 1991-10-24 1991-10-24 Kabi Pharmacia Ab New drug formulation
US6495154B1 (en) * 2000-11-21 2002-12-17 Vivus Inc. On demand administration of clomipramine and salts thereof to treat premature ejaculation
US20030099711A1 (en) * 2001-08-29 2003-05-29 David Meadows Sustained release preparations
MXPA04003567A (es) * 2001-10-17 2005-04-11 Minrad Inc Sistema de liberacion de farmacos para sedacion conciente.
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
JP6577024B2 (ja) * 2014-05-08 2019-09-18 シーティーシー バイオ インコーポレイテッド 味が遮蔽されたクロミプラミン含有経口投与用薬学製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH383552A (de) * 1958-10-24 1964-10-31 Clinical Products Limited Verfahren zur Herstellung von Harz-Arzneistoffverbindungen
US3138525A (en) * 1961-06-16 1964-06-23 Hoffmann La Roche Castor wax-amprotropine-resin compositions
US3140978A (en) * 1961-11-02 1964-07-14 Hoffmann La Roche Pharmaceutical composition containing complex magnesium aluminum silicate
US3337402A (en) * 1963-09-03 1967-08-22 Hoffmann La Roche Stable and palatable pharmaceutical composition

Also Published As

Publication number Publication date
GB1176194A (en) 1970-01-01
BE719263A (esLanguage) 1969-02-10
NL6811233A (esLanguage) 1969-02-14
IL30529A (en) 1972-04-27
CS159232B2 (esLanguage) 1974-12-27
MY7300271A (en) 1973-12-31
SE376548B (esLanguage) 1975-06-02
JPS4823889B1 (esLanguage) 1973-07-17
IL30529A0 (en) 1968-10-24
DK123141B (da) 1972-05-23
IE32264B1 (en) 1973-05-30
FI48974C (fi) 1975-03-10
CA920949A (en) 1973-02-13
FI48974B (esLanguage) 1974-12-02
DE1792233B1 (de) 1971-10-07
AT288592B (de) 1971-03-10
IE32264L (en) 1969-02-12
FR7751M (esLanguage) 1970-03-16
US3665073A (en) 1972-05-23
CY681A (en) 1973-04-26
NO128308B (esLanguage) 1973-10-29

Similar Documents

Publication Publication Date Title
ES357071A1 (es) Un procedimiento para la obtencion de un preparado farma- ceutico apto para administracion oral.
DE3852781T2 (de) Präparat mit verzögerter Freisetzung sowie dessen Herstellung.
JP2825202B2 (ja) 調剤用イオン交換樹脂組成物の製法
US4205060A (en) Microcapsules containing medicament-polymer salt having a water-insoluble polymer sheath, their production and their use
US20170340519A9 (en) Dual-chamber pack for extended release suspension compositions
GB1091078A (en) Process for enveloping fine droplets of dispersed liquids
CA2984725A1 (en) Dual-chamber pack for extended release suspension compositions
JPS5584543A (en) Flock for filtration and deionization adjusted from cation and anion emulsion ionnexchange resin
GB931149A (en) Dual coating process
GB935639A (en) Pharmaceutical compositions comprising drug/resin adsorbates
AU2017254908A1 (en) Dual-chamber pack for extended release suspension compositions
DK160601B (da) Farmaceutisk harpiksholdigt, sustained release praeparat med kontrolleret afgivelse af et farmaceutisk acceptabelt syreadditionssalt af dextromethorphan samt fremgangsmaade til fremstilling deraf
KR880000106A (ko) 지속적으로 방출하는 제약학적 제제
US20180133399A1 (en) Drug delivery device for pharmaceutical compositions
CA3023207C (en) Dual-chamber pack for pharmaceutical compositions
KR900011451A (ko) 새로운 의약품 제제
GB1422774A (en) Hydrogenation process for fatty acids and their derivatives
GB857194A (en) Therapeutic agents comprising ion-exchange resins
ES8405268A1 (es) Procedimiento de produccion de articulos solidos tales como tabletas y similares coloreados y portadores de al menos una talla en relieve.
US2990333A (en) Gelatin capsule with nu-alkyl amide, for aqueous vehicles
US2857311A (en) Dermatological mixture of ion-exchange resins
CA960824A (en) Wet-spinning polymer solution containing dispersion of solid in insoluble liquid
GB1176706A (en) Treatment of Liquids
JPS6335526A (ja) ポリマ−処理イオン交換樹脂
GB869149A (en) Liquid pharmaceutical compositions comprising compounds of ion exchange resins and therapeutic substances